Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WOODALL, NICHOLAS W | 1 | 82.2% | +13.1% |
| HA, JULIE | 1 | 75.6% | +44.2% |
| NICKOL, GARY B | 1 | 44.4% | +29.3% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18689178 | RIGID, CURVED LARYNGOSCOPE | WOODALL, NICHOLAS W | 33d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18553732 | FIBRIL PEPTIDES | HA, JULIE | — |
| 18274624 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | NICKOL, GARY B | — |
| 17921922 | ANTISENSE OLIGONUCLEOTIDES FOR INCREASING SHANK3 EXPRESSION | CHONG, KIMBERLY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18689178 | RIGID, CURVED LARYNGOSCOPE | WOODALL, NICHOLAS W | 33d |
| 18553732 | FIBRIL PEPTIDES | HA, JULIE | — |
| 18274624 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | NICKOL, GARY B | — |
| 17921922 | ANTISENSE OLIGONUCLEOTIDES FOR INCREASING SHANK3 EXPRESSION | CHONG, KIMBERLY | — |
| Art Unit | Apps |
|---|---|
| 3775 | 1 |
| 1654 | 1 |
| 1643 | 1 |
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18689178 | RIGID, CURVED LARYNGOSCOPE | WOODALL, NICHOLAS W | 3775 | §103 | Final Rejection | 33d | Pending | Mar 05, 2024 |
| 18553732 | FIBRIL PEPTIDES | HA, JULIE | 1654 | §102§103 | Non-Final OA | — | Pending | Oct 02, 2023 |
| 18274624 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | NICKOL, GARY B | 1643 | §101§102§112DP | Non-Final OA | — | Pending | Jul 27, 2023 |
| 17921922 | ANTISENSE OLIGONUCLEOTIDES FOR INCREASING SHANK3 EXPRESSION | CHONG, KIMBERLY | 1636 | §103§112 | Non-Final OA | — | Pending | Oct 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial